Sponsored by Allucent 23 Sep 2025 The Netherlands: A strategic gateway for biotech clinical trials Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong European impact. September 23, 2025 - 7 minutesmins - By Francina Agosti Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2025 GLP-1 drugs on WHO Essential Medicines List: what’s the impact? The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision. September 19, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Aug 2025 Five biotech companies in South Korea you should know about Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics areas. August 26, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Aug 2025 Injecting hope into skin cancer treatment: The promise of melanoma vaccines Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer. August 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Aug 2025 Zombie biotechs and the mission to make them disappear fast Zombie biotechs continue to exist despite setbacks. Some players in the industry want to free the capital and eliminate these companies. August 11, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success. August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2025 Oncolytic virus therapy for cancer: what’s been going on in 2025? This past year has seen various developments in the field of oncolytic virus therapies – in fundraising and in the clinic. August 1, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 30 Jul 2025 Targeting orexin: the future of narcolepsy treatments There are a few new narcolepsy treatments being tested in the clinic, and recently, some of them have made promising strides. But how far along are they? July 30, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? Discover twelve companies focused on genetic diseases that managed to close funding rounds in the last two years. July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 17 Jul 2025 New horizons in sickle cell disease treatment: Promising therapies on the way Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. July 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 16 Jul 2025 Eight rare autoimmune diseases biotechs are fighting to treat Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them. July 16, 2025 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 9 Jul 2025 New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage? Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval. July 9, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email